Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains

Clinical trial NCT06687473 · COMPLETED

Trial details

NCT number: NCT06687473
Sponsor: National Cheng-Kung University Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Helicobacter Pylori Drug Resistance, Multiple Virulence Factor

Start date: 2022-01-01
Primary completion: 2023-03-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.